Therapeutics for Alzheimer’s disease based on the metal hypothesis

[1]  C. Atwood,et al.  Metals and Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[2]  K. Blennow,et al.  Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid , 2009, Neurobiology of Aging.

[3]  A. Bush,et al.  Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms. , 2008, The Biochemical journal.

[4]  P. Palumaa,et al.  Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide , 2008, Journal of neurochemistry.

[5]  M. Stoltenberg,et al.  Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency , 2007, Neuroscience.

[6]  Tetsuya Suhara,et al.  Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography , 2007, The Journal of Neuroscience.

[7]  R. Mains,et al.  Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease , 2007, Neurobiology of Disease.

[8]  S. Mandel,et al.  Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG. , 2007, Current Alzheimer research.

[9]  A. Mehta,et al.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity , 2007, Proceedings of the National Academy of Sciences.

[10]  W. Markesbery,et al.  Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. , 2007, Archives of neurology.

[11]  C. Masters,et al.  Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau , 2007, PloS one.

[12]  Sangmi Jun,et al.  The aggregated state of amyloid-beta peptide in vitro depends on Cu2+ ion concentration. , 2007, Angewandte Chemie.

[13]  L. Ming,et al.  Metallo-ROS in Alzheimer's disease: oxidation of neurotransmitters by CuII-beta-amyloid and neuropathology of the disease. , 2007, Angewandte Chemie.

[14]  Chan Beum Park,et al.  Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. , 2007, Biochemistry.

[15]  P. Boyer,et al.  Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology , 2007, Proceedings of the National Academy of Sciences.

[16]  M. Kazachkov,et al.  Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease , 2007, Journal of Neural Transmission.

[17]  Gang Xiao,et al.  Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins* , 2007, Journal of Biological Chemistry.

[18]  R. Mains,et al.  ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis , 2007, Molecular and Cellular Neuroscience.

[19]  Astrid Gräslund,et al.  High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide , 2007 .

[20]  M. Youdim,et al.  Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1 , 2007, Journal of neurochemistry.

[21]  D. Birchall,et al.  Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. , 2006, Brain : a journal of neurology.

[22]  J. Danielsson,et al.  High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. , 2007, The FEBS journal.

[23]  D. Holtzman,et al.  Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity , 2006, Proceedings of the National Academy of Sciences.

[24]  M. Youdim,et al.  A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  C. Angelini,et al.  Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study , 2006, European journal of neurology.

[26]  J. Schneider,et al.  Dietary copper and high saturated and trans fat intakes associated with cognitive decline. , 2006, Archives of neurology.

[27]  V. Haroutunian,et al.  Elevated cortical zinc in Alzheimer disease , 2006, Neurology.

[28]  D. Sparks,et al.  Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. , 2006, The journal of nutrition, health & aging.

[29]  Antonio Lanzirotti,et al.  Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.

[30]  C. Masters,et al.  Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity* , 2006, Journal of Biological Chemistry.

[31]  Wen-Pin Hu,et al.  Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing , 2006, Journal of Neuroscience Methods.

[32]  Yaping Zeng,et al.  Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration , 2006, Journal of Neuroscience Methods.

[33]  S. Maiti,et al.  Selective destabilization of soluble amyloid β oligomers by divalent metal ions , 2006 .

[34]  J. Kraus,et al.  1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution. , 2006, Bioorganic & medicinal chemistry letters.

[35]  C. Masters,et al.  Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge* , 2006, Journal of Biological Chemistry.

[36]  S. Mandel,et al.  Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease , 2006, Journal of neurochemistry.

[37]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[38]  J. H. Viles,et al.  Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease. , 2006, Biochimica et biophysica acta.

[39]  C. Rowe,et al.  Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease , 2006, Aging cell.

[40]  R. Cherny,et al.  Dimerisation of N-acetyl-l-tyrosine ethyl ester and Aβ peptides via formation of dityrosine , 2006, Free radical research.

[41]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[42]  S. Maiti,et al.  Selective destabilization of soluble amyloid beta oligomers by divalent metal ions. , 2006, Biochemical and biophysical research communications.

[43]  F. Stellato,et al.  Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes , 2006, European Biophysics Journal.

[44]  J. LaManna,et al.  Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition , 2005, Journal of Biological Chemistry.

[45]  A. Bush,et al.  Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. , 2005, Journal of inorganic biochemistry.

[46]  C. Masters,et al.  In vitro gamma‐secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc , 2005, The FEBS journal.

[47]  P. Axelsen,et al.  Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins , 2005 .

[48]  S. Melov,et al.  Alzheimer disease β-amyloid activity mimics cholesterol oxidase , 2005 .

[49]  L. Ming,et al.  Alzheimer's disease related copper(II)- beta-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities. , 2005, Angewandte Chemie.

[50]  A. Hamby,et al.  Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Tanzi.  The synaptic Aβ hypothesis of Alzheimer disease , 2005, Nature Neuroscience.

[52]  J. Troncoso,et al.  Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques , 2005, Histochemistry and Cell Biology.

[53]  C. Masters,et al.  Methionine regulates copper/hydrogen peroxide oxidation products of Aβ , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[54]  A. Bush,et al.  The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.

[55]  K. Freeman,et al.  BACE1 Cytoplasmic Domain Interacts with the Copper Chaperone for Superoxide Dismutase-1 and Binds Copper* , 2005, Journal of Biological Chemistry.

[56]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[57]  D. Alkon,et al.  Oxidation of Cholesterol by Amyloid Precursor Protein and β-Amyloid Peptide* , 2005, Journal of Biological Chemistry.

[58]  R. Moreau,et al.  Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex , 2005, Redox report : communications in free radical research.

[59]  Yi Ai,et al.  Correlation of R2 with total iron concentration in the brains of rhesus monkeys , 2005, Journal of magnetic resonance imaging : JMRI.

[60]  A. Craig,et al.  NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons , 2005, The Journal of Neuroscience.

[61]  R. Tanzi.  The synaptic Abeta hypothesis of Alzheimer disease. , 2005, Nature neuroscience.

[62]  P. Axelsen,et al.  Promotion of oxidative lipid membrane damage by amyloid beta proteins. , 2005, Biochemistry.

[63]  D. Alkon,et al.  Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. , 2005, The Journal of biological chemistry.

[64]  D. Metodiewa.  Molecular mechanisms of cellular injury produced by neurotoxic amino acids that generate reactive oxygen species , 2005, Amino Acids.

[65]  A. Loguinov,et al.  Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. , 2004, Physiological genomics.

[66]  Xudong Huang,et al.  Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides , 2004, JBIC Journal of Biological Inorganic Chemistry.

[67]  J. Koh,et al.  The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice , 2004, Neurobiology of Aging.

[68]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[69]  C. Masters,et al.  Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution* , 2004, Journal of Biological Chemistry.

[70]  Colin L Masters,et al.  Gene knockout of amyloid precursor protein and amyloid precursor‐like protein‐2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts , 2004, Journal of neurochemistry.

[71]  C. Masters,et al.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  G. Multhaup,et al.  Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene* , 2004, Journal of Biological Chemistry.

[73]  Xudong Huang,et al.  Peroxidase Activity of Cyclooxygenase-2 (COX-2) Cross-links β-Amyloid (Aβ) and Generates Aβ-COX-2 Hetero-oligomers That Are Increased in Alzheimer's Disease* , 2004, Journal of Biological Chemistry.

[74]  R. Palmiter,et al.  Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.

[75]  R. Palmiter,et al.  Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain* , 2004, Journal of Biological Chemistry.

[76]  M. Vitek,et al.  Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. , 2004, Free radical biology & medicine.

[77]  Xudong Huang,et al.  Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. , 2004, Biochemistry.

[78]  Khadija Iqbal,et al.  Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia , 2004, Acta Neuropathologica.

[79]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[80]  D. Westaway,et al.  In vivo reduction of amyloid-β by a mutant copper transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  T. Bayer,et al.  Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[82]  D. Sparks,et al.  Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Duchen,et al.  Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity , 2003, The Journal of Neuroscience.

[84]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[85]  George Perry,et al.  Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.

[86]  C. Masters,et al.  Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid* , 2003, The Journal of Biological Chemistry.

[87]  P. S. St George-Hyslop,et al.  In vivo reduction of amyloid-beta by a mutant copper transporter. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[88]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[89]  Xudong Huang,et al.  An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.

[90]  Xudong Huang,et al.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.

[91]  T. Masumizu,et al.  Growth Inhibitory Factor Prevents Neurite Extension and the Death of Cortical Neurons Caused by High Oxygen Exposure through Hydroxyl Radical Scavenging* , 2002, The Journal of Biological Chemistry.

[92]  D. Allsop,et al.  Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease. , 2002 .

[93]  R. Tanzi,et al.  The galvanization of β-amyloid in Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[95]  P. Pasqualetti,et al.  d‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients , 2002, European journal of clinical investigation.

[96]  D. Allsop,et al.  Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. , 2002, Free radical biology & medicine.

[97]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[98]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[99]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[100]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[101]  G. Perry,et al.  Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .

[102]  Sang Won Suh,et al.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.

[103]  G. Perry,et al.  Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. , 2000, Journal of neuropathology and experimental neurology.

[104]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[105]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[106]  C. Masters,et al.  Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. , 1999, The Biochemical journal.

[107]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[108]  C. Masters,et al.  Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.

[109]  J. Trojanowski,et al.  The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.

[110]  Chris I. De Zeeuw,et al.  GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei , 1999, The Journal of Neuroscience.

[111]  Jae-Young Koh,et al.  Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[112]  R. Tanzi,et al.  Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. , 1999, Biochemistry.

[113]  George Perry,et al.  RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease , 1999, The Journal of Neuroscience.

[114]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[115]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[116]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[117]  Xudong Huang,et al.  Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors* , 1997, The Journal of Biological Chemistry.

[118]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[119]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[120]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[121]  P. Hof,et al.  A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. , 1997, European neurology.

[122]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[123]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[124]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[125]  C. Morris,et al.  Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[126]  C. Vigo‐Pelfrey,et al.  Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid , 1993 .

[127]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[128]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[129]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[130]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[131]  K. Titani,et al.  The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.

[132]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[133]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[134]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[135]  C. Cotman,et al.  β-Amyloid protein promotes neuritic branching in hippocampal cultures , 1990, Neuroscience Letters.

[136]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[137]  C. Frederickson.  Neurobiology of zinc and zinc-containing neurons. , 1989, International review of neurobiology.

[138]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[139]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[140]  A. Peters,et al.  The Structure of Neuritic Plaques in the Cerebral Cortex of Aged Rats , 1981, Journal of neuropathology and experimental neurology.